87 related articles for article (PubMed ID: 18081150)
1. The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection.
Einav S; Sklan EH; Moon HM; Gehrig E; Liu P; Hao Y; Lowe AW; Glenn JS
Hepatology; 2008 Mar; 47(3):827-35. PubMed ID: 18081150
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene.
Park JS; Yang JM; Min MK
Biochem Biophys Res Commun; 2000 Jan; 267(2):581-7. PubMed ID: 10631105
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway.
Pavio N; Battaglia S; Boucreux D; Arnulf B; Sobesky R; Hermine O; Brechot C
Oncogene; 2005 Sep; 24(40):6119-32. PubMed ID: 16007207
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
5. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of recombinant hepatitis C virus nonstructural protein 4B: evidence for ATP/GTP hydrolysis and adenylate kinase activity.
Thompson AA; Zou A; Yan J; Duggal R; Hao W; Molina D; Cronin CN; Wells PA
Biochemistry; 2009 Feb; 48(5):906-16. PubMed ID: 19146391
[TBL] [Abstract][Full Text] [Related]
7. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
8. A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication.
Einav S; Elazar M; Danieli T; Glenn JS
J Virol; 2004 Oct; 78(20):11288-95. PubMed ID: 15452248
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
10. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
[TBL] [Abstract][Full Text] [Related]
11. Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper.
Welker MW; Susser S; Welsch C; Perner D; Füller C; Kronenberger B; Herrmann E; Zeuzem S; Sarrazin C
J Viral Hepat; 2012 Nov; 19(11):775-83. PubMed ID: 23043384
[TBL] [Abstract][Full Text] [Related]
12. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts.
Schuster R; Gerlich WH; Schaefer S
Oncogene; 2000 Feb; 19(9):1173-80. PubMed ID: 10713705
[TBL] [Abstract][Full Text] [Related]
15. Amphipathic alpha-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B.
Gouttenoire J; Roingeard P; Penin F; Moradpour D
J Virol; 2010 Dec; 84(24):12529-37. PubMed ID: 20926561
[TBL] [Abstract][Full Text] [Related]
16. Viral hepatitis and liver cancer: the case of hepatitis C.
Levrero M
Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA.
Harada T; Kim DW; Sagawa K; Suzuki T; Takahashi K; Saito I; Matsuura Y; Miyamura T
J Gen Virol; 1995 May; 76 ( Pt 5)():1215-21. PubMed ID: 7730805
[TBL] [Abstract][Full Text] [Related]
18. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response.
Kong L; Li S; Yu X; Fang X; Xu A; Huang M; Wu X; Guo Y; Guo F; Xu J
Arch Virol; 2016 Aug; 161(8):2149-59. PubMed ID: 27180099
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
